ThursdayNov 16, 2023 1:08 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Release Interim Data by Year End for Lead Treatment Candidate Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company focused on developing innovative therapies for central nervous system disorders, specifically aggressive brain cancers. The company today announced its confidence in sharing the results from an interim analysis on one of its lead treatment candidates, Berubicin, with the public before the end of the year. Berubicin is a chemotherapy drug that interferes with the DNA of cancer cells to inhibit their growth and potentially shrink tumors. Distinct from other anthracyclines, a clinically trusted class of drugs in use for 60 years against dozens of common cancers, and other traditional chemotherapy drugs, CNS…

Continue Reading

WednesdayNov 15, 2023 3:26 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Advance Patented DehydraTECH(TM)

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is steadily advancing its patented DehydraTECH(TM) technology for a growing range of applications including oral nicotine, hypertension, antivirals, human hormone therapy, diabetes and more. Through previous clinical trials, DehydraTECH-processed CBD has shown its ability to lower blood pressure in patients over multiple weeks. “That we were able to lower blood pressure in our patient population over multiple weeks using DehydraTECH-CBD is an exceptional discovery, given that previous studies by others using other oral CBD formulations have failed to evidence this sustained benefit,” a recent article quotes Lexaria CEO…

Continue Reading

WednesdayNov 15, 2023 1:15 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Strong Preliminary Earnings for Q3

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning that offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region. The company has released its preliminary financial results for the third quarter of 2023. Among the highlights, the company reported annualized revenue growth of 27% quarter over quarter and a margin increase of 27% year over year. “We had another quarter of strong growth and improved profitability at a time when a number of large players in the freight market are facing severe…

Continue Reading

TuesdayNov 14, 2023 2:44 pm

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q1 Fiscal 2024 Financial Results, Provides Business Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today released financial results for the first quarter of the fiscal year 2024, which ended Sept. 30, 2023. “We are pleased with the continued advancements across our pharmaceutical programs and commercial operations. We are particularly excited with the recent candidate selection and official launch of our INM-901 preclinical program targeting the treatment of Alzheimer’s disease, representing a unique and innovative treatment approach compared to current options available to patients. Our commercial subsidiary, BayMedica, continues to make steady progress as a…

Continue Reading

MondayNov 13, 2023 12:30 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Expansion of US Battery Operations

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced a new high-energy facility in Fullerton, California, which expands the company’s overall U.S. footprint, including EV battery development and production capabilities. According to the announcement, the new Southern California facility is dedicated to producing next-generation American-made EV battery packs, a critical component to the company’s commitment to zero emissions. Mullen’s high-energy pilot facility in Monrovia, California, will be consolidated with the recently purchased Romeo Power assets at the company’s new high-energy and high-volume battery pack production facility in Fullerton, California. “We are one step closer to fulfilling our…

Continue Reading

FridayNov 10, 2023 1:26 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Announces Q3 2023 Results

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has announced business updates and financial results for the third quarter ended Sept. 30, 2023. Among the highlights, the company reported $3.8 million in total revenue for the third quarter of 2023, an increase of 112% compared to the prior year comparable period and 38% sequentially. The company attributed revenue growth to record shipment volumes. “For the second consecutive quarter, we set new company records for shipment volumes for the automotive end market,” said Jun Pei, Cepton’s co-founder and CEO. “Our continued dedication to executing our milestones…

Continue Reading

TuesdayNov 07, 2023 12:00 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) CEO Shares Open Letter to Shareholders

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company with a custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning offering a real-time portal for B2B cross-border shipping and domestic shipping within the USMCA region. The company today released an open letter from its CEO Javier Selgas addressing concerns regarding recent fluctuations in stock values. “In recent times, we’ve received inquiries about the downward trajectory of our stock... As the CEO of Fr8Tech, I hold your concerns in the highest regard. My paramount duty is to steer our company toward the realization of our objectives, and as I…

Continue Reading

TuesdayNov 07, 2023 9:47 am

TinyGemsBreaks – GEMXX Corporation (GEMZ) Releases Mining Update Report, Plans to Expand Capacity

GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment and a partner in Canadian gold-exploration company Crazy Horse Mining Inc. (“CHMI”), is reporting on its current and future mining plans for each of its operations. At Snow Creek, which the company operates in partnership with CHMI, GEMXX has completed gold production, processing a total of 31,200 cubic yards of gold-bearing ore yielding 0.929 ounces per 100 cubic yards. The company is compiling test and mining results and is planning to triple production at the site in 2024. The two companies plan to move the test plant used at…

Continue Reading

MondayNov 06, 2023 1:41 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Achieves Key Milestone with Receipt of EPA Certification for Class 1 EV Cargo Vans

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced full approval from the Environmental Protection Agency (“EPA”) that provides Mullen with the EPA’s Certificate of Conformity for Class 1 EV cargo vans on Nov. 2, 2023. Both Mullen’s commercial Class 1 and Class 3 EV vehicles have now received EPA certification (its Class 3 EV cab chassis truck received the certification on Sept. 22, 2023), which is a key milestone for selling vehicles in the U.S. Class 3 vehicle production began in August 2023 with the first vehicles rolling off the assembly line on Aug. 21, 2023,…

Continue Reading

FridayNov 03, 2023 2:52 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-Processed CBD Proven Superior in Research

Lexaria (NASDAQ: LEXX), a global innovator in drug delivery platforms, remains on track to submit an Investigational New Drug (“IND”) application for its planned U.S. Phase 1b Hypertension Clinical Trial HYPER H23-1. “Lexaria’s IND submission builds on five previous human clinical studies conducted from 2018 to 2022 and is integral to the successful filing and review of the submission. These studies were carried out in an aggregate total of 134 healthy and hypertensive persons and evidenced significant reductions in resting blood pressure over both acute and multi-week dosing regimens… The company is only aware of a handful of other published…

Continue Reading

Contact us: (512) 354-7000